Back to Search
Start Over
Systemic Biomarkers in 2-Phase Antibiotic Periodontal Treatment: A Randomized Clinical Trial.
- Source :
- Journal of Dental Research; Mar2016, Vol. 95 Issue 3, p349-355, 7p, 1 Diagram, 3 Charts, 1 Graph
- Publication Year :
- 2016
-
Abstract
- Accumulating evidence suggests that periodontal infections may have an impact on systemic health. In patients with untreated periodontitis, very high values for several inflammatory markers in serum are expressed simultaneously. We investigated to what extent these peak values change after nonsurgical and surgical periodontal treatment, with adjunctive antibiotics administered during the first or the second treatment phase. In a single-center, randomized, placebo-controlled, and double-masked clinical trial, 80 patients with chronic or aggressive periodontitis were randomized into 2 treatment groups: group A, receiving systemic amoxicillin and metronidazole during the first, nonsurgical phase of periodontal therapy (phase 1), and group B, receiving the antibiotics during the second, surgical phase (phase 2). Serum samples were obtained at baseline (BL), 3 mo after phase 1 (M3), and 6 and 12 mo after phase 2 (M6, M12). Samples were evaluated for 15 cytokines and 9 acute-phase proteins using the Bio-Plex bead array multianalyte detection system. For each analyte, peak values were defined as greater than mean +2 SD of measurements found in 40 periodontally healthy persons. Sixty-six patients showed a peak value of at least 1 analyte at BL. At M12, the number of these patients was only 36 (P = 0.0002). This decrease was stronger in group A (BL: 35, M12: 19, P = 0.0009) than in group B (BL: 31, M12: 17, P = 0.14). Twenty patients displayed peak values of at least 4 biomarkers at BL. The nonsurgical therapy delivered in the first phase reduced most of these peaks (group A, BL: 9, M3: 4, P = 0.17; group B, BL: 11, M3: 2, P = 0.01), irrespective of adjunctive antibiotics. The reductions obtained at M3 were maintained until M12 in both groups. Initial, nonsurgical periodontal therapy reduced the incidence of peak levels of inflammatory markers. Antibiotics and further surgical therapy did not enhance the effect (Clinicaltrials.gov NCT02197260). [ABSTRACT FROM AUTHOR]
- Subjects :
- PERIODONTAL disease
PERIODONTITIS
BIOMARKERS
ANTIBIOTICS
RANDOMIZED controlled trials
CLINICAL trials
AMOXICILLIN
METRONIDAZOLE
GLYCOPROTEIN analysis
ACUTE phase proteins
BLOOD proteins
CALCITONIN
CHRONIC diseases
COMBINED modality therapy
COMPARATIVE studies
CYTOKINES
DEBRIDEMENT
FERRITIN
GLOBULINS
INFLAMMATORY mediators
INTERLEUKINS
LONGITUDINAL method
RESEARCH methodology
MEDICAL cooperation
PLACEBOS
PROTEIN precursors
PROTEINS
RESEARCH
EVALUATION research
BLIND experiment
AGGRESSIVE periodontitis
THERAPEUTICS
Subjects
Details
- Language :
- English
- ISSN :
- 00220345
- Volume :
- 95
- Issue :
- 3
- Database :
- Complementary Index
- Journal :
- Journal of Dental Research
- Publication Type :
- Academic Journal
- Accession number :
- 113263788
- Full Text :
- https://doi.org/10.1177/0022034515618949